International Clinical Trial: Safety and Efficacy of HRS-9190 Compared to Cisatracurium for Continuous Intravenous Infusion in Adults

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07446309) titled 'Safety and Efficacy of HRS-9190 Compared to Cisatracurium for Continuous Intravenous Infusion in Adults' on Feb. 26.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Jiangsu HengRui Medicine Co., Ltd.

Condition: Neuromuscular Blockade

Intervention: Drug: HRS-9190 under Inhalational Anesthesia Drug: HRS-9190 under Intravenous Anesthesia Drug: Cisatracurium (under Inhalational Anesthesia).

Recruitment Status: Not recruiting

Phas...